Search results
Results from the WOW.Com Content Network
Thermo Fisher Scientific's previous headquarters in Waltham, Massachusetts Thermo Fisher Scientific office in Canada. Thermo Fisher Scientific Inc. is an American life, science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and ...
PPD has its headquarters in Wilmington, North Carolina. The company has more than 27,000 employees. As of December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific, based in Waltham, Massachusetts.
On May 27, 2016, Thermo Fisher Scientific Inc. announced [9] its acquisition of FEI Company for US$4.2 billion, which commenced in early 2017. [10] At the time of the transaction, FEI had more than 2700 employees in over 20 countries. [11] The FEI trademark was phased out in favor of the Materials & Structural Analysis division of Thermo Fisher ...
Fisher Scientific International, Inc. (NYSE: FSH [1]) was a laboratory supply and biotechnology company that provided products and services to the global scientific research and clinical laboratory markets until its merger with Thermo Electron in 2006, after which it became Thermo Fisher Scientific.
The latter was acquired by Thermo Fisher Scientific in 2014. Prior to 2008, the Applied Biosystems brand was owned by various entities in a corporate group parented by PerkinElmer. The roots of Applied Biosystems trace back to GeneCo (Genetic Systems Company), a pioneer biotechnology company founded in 1981 in Foster City, California. [1]
The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques. [5] [6]
2020 Thermo Fisher Acquisition Target [ edit ] On March 3, 2020, Thermo Fisher Scientific announced plans for the acquisition of QIAGEN at €39 per share in cash, which valued the transaction at $11.5 billion at the time. [ 34 ]
In 2000, the company opened a central laboratory in Singapore, building on clinical-development services formed in Singapore in 1996. [10] [11] In 2013, it expanded the capacity of the laboratory by 50%. [12] [13] [14] In March 2001, the company sold Covance Pharmaceutical Packaging Services to Fisher Scientific for $137.5 million. [15] [16] [17]